Provided by Tiger Trade Technology Pte. Ltd.

Pliant Therapeutics, Inc.

1.34
-0.0700-4.96%
Volume:223.46K
Turnover:305.70K
Market Cap:82.97M
PE:-0.56
High:1.44
Open:1.41
Low:1.33
Close:1.41
52wk High:1.95
52wk Low:1.09
Shares:61.91M
Float Shares:55.57M
Volume Ratio:1.87
T/O Rate:0.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4121
EPS(LYR):-3.4739
ROE:-64.27%
ROA:-32.87%
PB:0.41
PE(LYR):-0.39

Loading ...

Nov 09, 2021

Major Issues Report

8-K - Current report
Sep 07, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 02, 2021

Major Issues Report

8-K - Current report
May 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2021

Major Issues Report

8-K - Current report
Mar 16, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 16, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 16, 2021

Major Issues Report

8-K - Current report
Mar 02, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 13, 2021

Major Issues Report

8-K - Current report
Dec 21, 2020

Major Issues Report

8-K - Current report
Nov 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2020

Major Issues Report

8-K - Current report
Aug 11, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]